Tag Archives: Diovan
-
-
Valsartan Recalls Are “Stress Test” For U.S. Drug Supply Chain: NEJM Editorial
-
Generic Valsartan Shortages Following Contamination Recalls Lead FDA To Prioritize Approval of New Drugs
-
Valsartan Contamination Lawsuits Stayed Pending Entry of Case Management Order
-
Generic Drug Safety Concerns Refuted By FDA Amid Continuing Valsartan Recall Problems
-
Valsartan Impurity Problems May Have Resulted From Attempts to Increase Yield: Report
-
Valsartan Recall Lawsuits Centralized in Federal Multidistrict Litigation
-
Consolidation of Valsartan Lawsuits Will Be Considered By JPML In January
-
Valsartan Wrongful Death Lawsuit Filed Over Kidney Cancer From Recalled Drug
-
Valsartan Lawsuit Claims Manufacturers Deceived Consumers Over Drugs’ Safety